About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study of LUMIGAN® RC in the Clinical Setting

NCT01833741·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Allergan

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Elevated IOP due to either primary open-angle glaucoma or ocular hypertension
Determined by the treating physician to require treatment with LUMIGAN® RC

You may not be if

None

The record

StatusCompleted

PhasePhase 4

Taking part1,137

StartedDec 2009

UpdatedSep 26, 2013

Conditions

Glaucoma, Primary Open Angle Ocular Hypertension

Where1

Barrie, Ontario, Canada

Clareo Health | A Study of LUMIGAN® RC in the Clinical Setting